PTC Therapeutics PTCT D&A

D&A at other companies

Sarepta Therapeutics, Inc.SRPT

$10.41M-4.0%

BioMarin PharmaceuticalsBMRN

$97.64M+426%

Capricor TherapeuticsCAPR

$534.67K+31.9%

ALN

Alnylam PharmaceuticalsALNY

$13.9M-0.3%

Edgewise Therapeutics, Inc.EWTX

$537K+4.7%

Dyne Therapeutics, Inc.DYN

$550K+9.6%

FAQ

What is PTC Therapeutics's D&A?

PTC Therapeutics (PTCT) reported D&A of $15.41M in Q1 2026.

How has PTC Therapeutics's D&A changed year-over-year?

PTC Therapeutics's D&A increased by 113.4% year-over-year, from $7.22M to $15.41M.

What is the long-term trend for PTC Therapeutics's D&A?

Over 4 years (2021 to 2025), PTC Therapeutics's D&A has grown at a -11.8% compound annual growth rate (CAGR), from $64.13M to $38.82M.

What does D&A mean?

Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.